JV Synergy Leverage the Teva Takeda joint venture heritage to position a unified portfolio of generic molecules, authorized generics, LLPs, and specialty assets as a cost-effective, diversified solution for Japanese customers, highlighting combined marketing and distribution strengths.

Japan Focus Target rationales around Japan’s established distribution network and Takeda’s brand reputation to pursue opportunities with hospital and retail channels seeking reliable, locally supported generic and specialty products.

Portfolio Leverage Offer a mix of widely used generics and specialty assets to meet unmet patient needs, emphasizing a robust pipeline alongside current products to appeal to buyers looking for continuity and incremental innovation.

Cost and Compliance Highlight financial discipline and proven commercialization expertise from Teva and Takeda to address procurement and regulatory compliance concerns, supporting lower total cost of ownership for healthcare providers.

Digital Readiness Promote digital contracting and document workflows (DocuSign, secure electronic processes) to streamline procurement cycles with Japanese customers and reduce administrative friction in supplier onboarding.